Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (S)-nicotine | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | Nicotine results in decreased expression of FAM120A mRNA | CTD | PMID:17997037 | 1,2-dimethylhydrazine | multiple interactions | ISO | Fam120a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM120A mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FAM120A mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FAM120A mRNA | CTD | PMID:33387578 | 2-methylcholine | affects expression | ISO | FAM120A (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of FAM120A mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAM120A mRNA more ... | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FAM120A mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM120A mRNA | CTD | PMID:36041667 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of FAM120A mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | Fam120a (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of FAM120A mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | FAM120A (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of FAM120A intron | CTD | PMID:30157460 | aflatoxin B1 | decreases methylation | ISO | FAM120A (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of FAM120A gene | CTD | PMID:27153756 | Aflatoxin B2 alpha | increases methylation | ISO | FAM120A (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of FAM120A intron | CTD | PMID:30157460 | arsenite(3-) | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to FAM120A mRNA] | CTD | PMID:32406909 | atrazine | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Atrazine results in increased expression of FAM120A mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | ISO | FAM120A (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FAM120A intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FAM120A mRNA | CTD | PMID:25047013 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM120A mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FAM120A mRNA | CTD | PMID:33221593 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of FAM120A gene | CTD | PMID:28505145 | bisphenol A | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAM120A mRNA | CTD | PMID:28628672 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FAM120A mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FAM120A mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FAM120A mRNA | CTD | PMID:36041667 | butanal | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of FAM120A mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of FAM120A mRNA | CTD | PMID:33453195 | cadmium dichloride | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of FAM120A mRNA | CTD | PMID:26472689 | caffeine | affects phosphorylation | ISO | FAM120A (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of FAM120A protein | CTD | PMID:35688186 | cisplatin | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of FAM120A mRNA | CTD | PMID:27594783 | cobalt dichloride | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of FAM120A mRNA | CTD | PMID:19320972 | crocidolite asbestos | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Asbestos and Crocidolite results in decreased expression of FAM120A mRNA | CTD | PMID:29523930 | dexamethasone | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAM120A mRNA more ... | CTD | PMID:28628672 | dicrotophos | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | dicrotophos results in increased expression of FAM120A mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM120A mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of FAM120A mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FAM120A protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Fam120a (Mus musculus) | 6480464 | Ethanol affects the splicing of FAM120A mRNA | CTD | PMID:30319688 | folic acid | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | Folic Acid results in decreased expression of FAM120A mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | Fam120a (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM120A mRNA | CTD | PMID:22206623 | formaldehyde | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of FAM120A mRNA | CTD | PMID:23649840 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of FAM120A mRNA | CTD | PMID:33387578 | hexadecanoic acid | decreases phosphorylation | ISO | FAM120A (Homo sapiens) | 6480464 | Palmitic Acid results in decreased phosphorylation of FAM120A protein | CTD | PMID:28073184 | hydralazine | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM120A mRNA | CTD | PMID:17183730 | hydrogen peroxide | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of FAM120A mRNA | CTD | PMID:18951874 | indometacin | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FAM120A mRNA more ... | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of FAM120A protein | CTD | PMID:32959892 | methidathion | increases expression | ISO | Fam120a (Mus musculus) | 6480464 | methidathion results in increased expression of FAM120A mRNA | CTD | PMID:34813904 | methyl methanesulfonate | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of FAM120A mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of FAM120A mRNA | CTD | PMID:26272509 | methylmercury chloride | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM120A mRNA | CTD | PMID:27188386 | nicotine | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | Nicotine results in decreased expression of FAM120A mRNA | CTD | PMID:17997037 | ozone | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of FAM120A mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FAM120A mRNA | CTD | PMID:21420995 and PMID:22230336 | SB 431542 | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM120A mRNA | CTD | PMID:27188386 | sunitinib | decreases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of FAM120A mRNA | CTD | PMID:31533062 | thapsigargin | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of FAM120A protein | CTD | PMID:24648495 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of FAM120A mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | trichostatin A results in increased expression of FAM120A mRNA | CTD | PMID:24935251 | tungsten | decreases expression | ISO | Fam120a (Mus musculus) | 6480464 | Tungsten results in decreased expression of FAM120A mRNA | CTD | PMID:30912803 | valproic acid | multiple interactions | ISO | FAM120A (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of FAM120A mRNA | CTD | PMID:17183730 | valproic acid | decreases methylation | ISO | FAM120A (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of FAM120A gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | FAM120A (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FAM120A mRNA | CTD | PMID:23179753 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of FAM120A mRNA | CTD | PMID:23034163 | |